Proteomics International has formed a partnership with Bioplatforms Australia and the University of Western Australia to launch a world leading facility in Western Australia.
The partners will co-invest A$4.4m over the next four years with Proteomics International’s contribution being $1.25m in Capex and Opex, representing outstanding value for the enhanced capabilities the facility will offer.